Literature DB >> 27185063

Effects of zinc oxide nanoparticles on human coronary artery endothelial cells.

Kai-Jen Chuang1, Kang-Yun Lee2, Chih-Hong Pan3, Ching-Huang Lai4, Lian-Yu Lin5, Shu-Chuan Ho6, Kin-Fai Ho7, Hsiao-Chi Chuang8.   

Abstract

Inhalation of zinc oxide (ZnO) metal fumes is known to cause metal fume fever and to have systemic effects; however, the effects of ZnO nanoparticles (ZnONPs) on the cardiovascular system remain unclear. The objective of this study was to investigate the cardiovascular toxicity of ZnONPs. Human coronary artery endothelial cells (HCAECs) were exposed to ZnONPs of different sizes to investigate the cell viability, 8-hydroxy-2'-deoxyguanosine (8-OHdG), interleukin (IL)-6, nitric oxide (NO), and regulation of cardiovascular disease-related genes. Exposure of HCAECs to ZnONPs resulted in decreased cell viability and increased levels of 8-OHdG, IL-6, and NO. Downregulation of cardiovascular-associated genes was observed in response to ZnONPs in HCAECs determined by qPCR, suggesting that the calcium signaling pathway, neuroactive ligand-receptor interaction, hypertrophic cardiomyopathy, dilated cardiomyopathy, and renin-angiotensin system are important affected pathways in response to ZnONPs. Furthermore, we observed a significant response of AGTR1 to ZnONP exposure in HCAECs. Our results suggest that ZnONPs cause toxicity to HCAECs, which could be associated with cardiovascular dysfunction.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AGTR1; Inflammation; Nanoparticles; Nitric oxide; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27185063     DOI: 10.1016/j.fct.2016.05.008

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  8 in total

Review 1.  Nanoparticle Effects on Stress Response Pathways and Nanoparticle-Protein Interactions.

Authors:  Shana J Cameron; Jessica Sheng; Farah Hosseinian; William G Willmore
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

2.  Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells.

Authors:  Ding-Ping Bai; Xi-Feng Zhang; Guo-Liang Zhang; Yi-Fan Huang; Sangiliyandi Gurunathan
Journal:  Int J Nanomedicine       Date:  2017-09-05

3.  Effects of Zinc Oxide Nanoparticles in HUVEC: Cyto- and Genotoxicity and Functional Impairment After Long-Term and Repetitive Exposure in vitro.

Authors:  Nikolaus Poier; Johannes Hochstöger; Stephan Hackenberg; Agmal Scherzad; Maximilian Bregenzer; Dominik Schopper; Norbert Kleinsasser
Journal:  Int J Nanomedicine       Date:  2020-06-22

4.  Zinc Oxide Nanoparticles Induce Mitochondrial Biogenesis Impairment and Cardiac Dysfunction in Human iPSC-Derived Cardiomyocytes.

Authors:  Yujie Li; Fengxiang Li; Lincong Zhang; Chi Zhang; Hui Peng; Feng Lan; Shuangqing Peng; Chao Liu; Jiabin Guo
Journal:  Int J Nanomedicine       Date:  2020-04-21

5.  Heterozygous Disruption of Beclin 1 Alleviates Zinc Oxide Nanoparticles-Induced Disturbance of Cholesterol Biosynthesis in Mouse Liver.

Authors:  Xuemei Liu; Bin Wang; Xuejun Jiang; Jun Zhang; Qianghu Tang; Yujia Zhang; Xia Qin; Chengzhi Chen; Zhen Zou
Journal:  Int J Nanomedicine       Date:  2019-12-12

Review 6.  Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities.

Authors:  Mohammad Javad Hajipour; Mehdi Mehrani; Seyed Hesameddin Abbasi; Ahmad Amin; Seyed Ebrahim Kassaian; Jessica C Garbern; Giulio Caracciolo; Steven Zanganeh; Mitra Chitsazan; Haniyeh Aghaverdi; Seyed Mehdi Kamali Shahri; Aliakbar Ashkarran; Mohammad Raoufi; Holly Bauser-Heaton; Jianyi Zhang; Jochen D Muehlschlegel; Anna Moore; Richard T Lee; Joseph C Wu; Vahid Serpooshan; Morteza Mahmoudi
Journal:  Chem Rev       Date:  2019-09-06       Impact factor: 60.622

Review 7.  Nanomaterials for treating cardiovascular diseases: A review.

Authors:  Wensen Jiang; Dana Rutherford; Tiffany Vuong; Huinan Liu
Journal:  Bioact Mater       Date:  2017-12-06

Review 8.  Nanoparticles as a Tool in Neuro-Oncology Theranostics.

Authors:  Andrea L Klein; Grant Nugent; John Cavendish; Werner J Geldenhuys; Krishnan Sriram; Dale Porter; Ross Fladeland; Paul R Lockman; Jonathan H Sherman
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.